Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Hematopoietic Stem Cell Transplantation. Found 17 abstracts

Costa LJ, Maddocks K, Epperla N, Reddy NM, Karmali R, Umyarova E, Bachanova V, Costa C, Glenn MJ, Chavez JC, Calzada O, Lansigan F, Nasheed H, Barta SK, Zhou Z, Jaglal M, Chhabra S, Hernandez-Ilizaliturri F, Xavier AC, Mehta A, Peker D, Forero-Torres A, Al-Mansour Z, Evens AM, Cohen JB, Flowers CR, Fenske TS, Hamadani M. Diffuse large B-cell lymphoma with primary treatment failure: Ultra-high risk features and benchmarking for experimental therapies. American journal of hematology. 2017 Feb;92(2):161-70.   PMCID: PMC5549936
Epperla N, Maddocks KJ, Salhab M, Chavez JC, Reddy N, Karmali R, Umyarova E, Bachanova V, Costa C, Glenn M, Calzada O, Xavier AC, Zhou Z, Hossain NM, Hernandez-Ilizaliturri FJ, Al-Mansour Z, Barta SK, Chhabra S, Lansigan F, Mehta A, Jaglal MV, Evans A, Flowers CR, Cohen JB, Fenske TS, Hamadani M, Costa LJ. C-MYC-positive relapsed and refractory, diffuse large B-cell lymphoma: Impact of additional "hits" and outcomes with subsequent therapy. Cancer. 2017 Nov 15;123(22):4411-8.
Muffly L, Pasquini MC, Martens M, Brazauskas R, Zhu X, Adekola K, Aljurf M, Ballen KK, Bajel A, Baron F, Battiwalla M, Beitinjaneh A, Cahn JY, Carabasi M, Chen YB, Chhabra S, Ciurea S, Copelan E, D'Souza A, Edwards J, Foran J, Freytes CO, Fung HC, Gale RP, Giralt S, Hashmi SK, Hildebrandt GC, Ho V, Jakubowski A, Lazarus H, Luskin MR, Martino R, Maziarz R, McCarthy P, Nishihori T, Olin R, Olsson RF, Pawarode A, Peres E, Rezvani AR, Rizzieri D, Savani BN, Schouten HC, Sabloff M, Seftel M, Seo S, Sorror ML, Szer J, Wirk BM, Wood WA, Artz A. Increasing use of allogeneic hematopoietic cell transplantation in patients age 70 years and older in the United States. Blood. 2017 Jul 03;130(9):1156-64.   PMCID: PMC5580273
Hossain NM, Klumpp T, Ulicny J, Garner M, Kropf PL, Mangan KF, Barta SK, Fung HC, Martin ME. Donor Lymphocyte Infusion in Hematologic Malignancies--Good to be Fresh?. Clinical lymphoma, myeloma & leukemia. 2016 Feb;16(2):111-5.
Meng L, Bai Z, He S, Mochizuki K, Liu Y, Purushe J, Sun H, Wang J, Yagita H, Mineishi S, Fung H, Yanik GA, Caricchio R, Fan X, Crisalli LM, Hexner EO, Reshef R, Zhang Y, Zhang Y. The Notch Ligand DLL4 Defines a Capability of Human Dendritic Cells in Regulating Th1 and Th17 Differentiation. J Immunol. 2016 Feb;196(3):1070-80.   PMCID: PMC4930627
Punwani D, Zhang Y, Yu J, Cowan MJ, Rana S, Kwan A, Adhikari AN, Lizama CO, Mendelsohn BA, Fahl SP, Chellappan A, Srinivasan R, Brenner SE, Wiest DL, Puck JM. Multisystem Anomalies in Severe Combined Immunodeficiency with Mutant BCL11B. The New England journal of medicine. 2016 Dec;375(22):2165-76.   PMCID: PMC5215776
Nelson J, Wu Y, Jiang X, Berretta R, Houser S, Choi E, Wang J, Huang J, Yang X, Wang H. Hyperhomocysteinemia suppresses bone marrow CD34+/VEGF receptor 2+ cells and inhibits progenitor cell mobilization and homing to injured vasculature-a role of beta1-integrin in progenitor cell migration and adhesion. FASEB J. 2015 Jul;29(7):3085-99.   PMCID: PMC4478803
Saez B, Ferraro F, Yusuf RZ, Cook CM, Yu VW, Pardo-Saganta A, Sykes SM, Palchaudhuri R, Schajnovitz A, Lotinun S, Lymperi S, Mendez-Ferrer S, Toro RD, Day R, Vasic R, Acharya SS, Baron R, Lin CP, Yamaguchi Y, Wagers AJ, Scadden DT. Inhibiting stromal cell heparan sulfate synthesis improves stem cell mobilization and enables engraftment without cytotoxic conditioning. Blood. 2014 Nov 06;124(19):2937-47.   PMCID: Pmc4224192
Wirk B, Klumpp TR, Ulicny J, Herman JH, Gajewski JL, Martin ME, Emmons RV, Mangan KF. Lack of effect of donor-recipient Rh mismatch on outcomes after allogeneic hematopoietic stem cell transplantation. Transfusion. 2008 Jan;48(1):163-8.
Parsons SK, Shih MC, Duhamel KN, Ostroff J, Mayer DK, Austin J, Martini DR, Williams SE, Mee L, Sexson S, Kaplan SH, Redd WH, Manne S. Maternal perspectives on children's health-related quality of life during the first year after pediatric hematopoietic stem cell transplant. J Pediatr Psychol. 2006 Nov;31(10):1100-15.
Jillella AP, Ustun C. What is the optimum number of CD34+ peripheral blood stem cells for an autologous transplant?. Stem Cells & Development. 2004 Dec;13(6):598-606.
Manne S, DuHamel K, Ostroff J, Parsons S, Martini DR, Williams SE, Mee L, Sexson S, Austin J, Difede J, Rini C, Redd WH. Anxiety, depressive, and posttraumatic stress disorders among mothers of pediatric survivors of hematopoietic stem cell transplantation. Pediatrics. 2004 Jun;113(6):1700-8.
Laport GG, Levine BL, Stadtmauer EA, Schuster SJ, Luger SM, Grupp S, Bunin N, Strobl FJ, Cotte J, Zheng Z, Gregson B, Rivers P, Vonderheide RH, Liebowitz DN, Porter DL, June CH. Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation. Blood. 2003 Sep 15;102(6):2004-13.
Manne S, DuHamel K, Winkel G, Ostroff J, Parsons S, Martini R, Williams SE, Mee L, Austin J, Redd WH. Perceived partner critical and avoidant behaviors as predictors of anxious and depressive symptoms among mothers of children undergoing hemopaietic stem cell transplantation. J Consult Clin Psychol. 2003 Dec;71(6):1076-83.
Shen M, Schilder RJ, Obasaju C, Gallo JM. Population pharmacokinetic and limited sampling models for carboplatin administered in high-dose combination regimens with peripheral blood stem cell support. Cancer Chemother Pharmacol. 2002 Sep;50(3):243-50.
Schilder RJ, Gallo JM, Millenson MM, Bookman MA, Weiner LM, Rogatko A, Rogers B, Padavic-Shallers K, Boente M, Rosenblum N, Adams AL, Ciccotto S, Ozols RF. Phase I trial of multiple cycles of high-dose carboplatin, paclitaxel, and topotecan with peripheral-blood stem-cell support as front-line therapy. J Clin Oncol. 2001 Feb 15;19(4):1183-94.
Schilder RJ, Goldberg M, Millenson MM, Movsas B, Rogatko A, Rogers B, Langer CJ. Phase II trial of induction high-dose chemotherapy followed by surgical resection and radiation therapy for patients with marginally resectable non-small cell carcinoma of the lung. Lung Cancer. 2000 Jan;27(1):37-45.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Hematopoietic Stem Cell Transplantation

Hematopoietic Stem Cell Transplantation Male Female Adult therapeutic use therapy Antineoplastic Combined Chemotherapy Protocols Human Treatment Outcome genetics mortality Aged methods Middle Aged Follow-Up Studies immunology Hematopoietic Stem Cells pathology administration & dosage drug therapy Homologous Transplantation Middle Age Adolescent Child Non-US Gov't Support Carboplatin metabolism Combined Modality Therapy US Gov't Support-PHS CD34 Antigens Anxiety adverse Autologous Transplantation Cell Movement Graft vs Host Disease psychology effects Retrospective Studies adverse effects Recurrence Animal Disease Models deficiency Transgenic Mice Disease-Free Survival Mothers pharmacokinetics Preschool Child Granulocyte Colony-Stimulating Factor Paclitaxel Depression physiology Green Fluorescent Proteins Hematopoietic Stem Cell Mobilization Inbred C57BL Mice Bone Marrow Cells (HSCT) METHODS: A total of 111 mothers of children who survived CD34) 0 (Antigens Allografts Severe Combined Immunodeficiency Personality Inventory Lymphoma diagnostic imaging Genes Lymphocytosis Stomatitis Lung Neoplasms Flow Cytometry Dendritic Cells Topotecan Competitive Binding cell therapy basic helix-loop-helix (MYC) their general quality of life Mothers who had 1 of the 4 diagnoses children who survive HSCT may require psychological intervention Real-Time Polymerase Chain Reaction Age Factors Western Blotting Carotid Artery Injuries Survival Analysis CD29 Antigens Antigen Receptors-T-Cell Disease Progression psychiatric interview 18 months after HSCT Demographic data and Transplantation Conditioning Multivariate Analysis Brain 80 and over Aged Area Under Curve Tissue Donors Remission Induction Hyperhomocysteinemia suggesting that the diagnoses had an impact on quality of life third of mothers met the criterion for persistent distress Mothers Colony-Forming Units Assay endothelial repair Demography Local Neoplasm Recurrence Non-Hodgkin non-Hodgkin lymphoma Cost of Illness Infant Persistent or relapsed disease Multiple Abnormalities px [Psychology] MH - Human MH - Logistic Models MH - Mothers transplantation US Gov't et [Etiology] MH - Support-PHS M Non-Small-Cell Lung Carcinoma Event-free survival Opportunistic Infections cy [Cytology] Magnetic Resonance Imaging Salvage Therapy Proportional Hazards Models Hospitalization Hematologic Neoplasms Cell Adhesion of children who underwent hematopoietic stem cell transplantation Young Adult Defense Mechanisms Lymphocyte Transfusion Rh-Hr Blood-Group System Th17 Cells et [Etiology] growth & development Prospective Studies symptoms at the time of HSCT CONCLUSIONS: A subset of mothers of with 1 of the 4 psychiatric diagnoses reported a significantly lower biosynthesis Heparin cytology drug effects myc Social Support Psychological Adaptation Th1 Cells myc Genes physiopathology Adenocarcinoma N-Acetylglucosaminyltransferases depressive symptoms at the time of transplantation Blood Component Transfusion hematopoietic cell transplantation (HCT) Prognosis Survival Histocompatibility Neoplasm Drug Resistance Predictive Value of Tests Marriage Rituximab Cytarabine
Last updated on Friday, February 02, 2018